Announcing this acquisition, Barbara Heumann, Managing Director, said, "I am incredibly proud to have grown GXP Engaged Auditing Services into the business it is today and am delighted to be handing over to Ian, André and the Kester team. I am confident their collective experience and expertise, supported by the incumbent team, will help GXP Engaged Auditing Services to achieve great success."
Incoming CEO, Ian Montague, added, “I am delighted to be working alongside the team at Kester Capital. GXP Engaged Auditing Services is well-positioned to accelerate its growth and Kester’s long and successful track record in the Life Sciences sector makes it the perfect partner as we move into this next phase.”
Managing partner of Kester Capital, Adam Maidment, went on to say, "This is a sector that Kester knows well and GXP Engaged Auditing Services is a well-established provider of audit and consulting services to some of the largest pharmaceutical companies in the world. It has an excellent reputation and we are delighted to have the opportunity to partner with Ian, André and the existing team to accelerate growth of the business, both organically and through acquisition.”
GXP Engaged Auditing Services will maintain our commitment to ensuring quality and compliance, identifying continuous improvements to industry best practices, in addition to our team of quality management professionals developing innovative tools and approaches.
Please do not hesitate to contact us using the email button below.
